Dr. Ray C. Pais
Claim this profileEast Tennessee Childrens Hospital
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
8 reported clinical trials
30 drugs studied
Area of expertise
1Leukemia
BCR-ABL1 fusion positive
ABL-class fusion positive
Philadelphia chromosome positive
2Lymphoblastic Leukemia-Lymphoma
BCR-ABL1 fusion positive
ABL-class fusion positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Ray C. Pais is currently running
Imatinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This trial tests how well the drug imatinib works with different chemotherapy treatments for patients with specific types of leukemia. It aims to find out if a less intense chemotherapy regimen can be as effective as a stronger one but with fewer side effects. The study focuses on patients with certain types of acute lymphoblastic leukemia.
Recruiting2 awards Phase 3
Stopping Tyrosine Kinase Inhibitors
for Chronic Myeloid Leukemia
This phase II trial studies how stopping tyrosine kinase inhibitors will affect treatment-free remission in patients with chronic myeloid leukemia in chronic phase. When the level of disease is very low, it's called molecular remission. TKIs are a type of medication that help keep this level low. However, after being in molecular remission for a specific amount of time, it may not be necessary to take tyrosine kinase inhibitors. It is not yet known whether stopping tyrosine kinase inhibitors will help patients with chronic myeloid leukemia in chronic phase continue or re-achieve molecular remission.
Recruiting1 award Phase 215 criteria
More about Ray C. Pais
Clinical Trial Related18 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Ray C. Pais has experience with
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Cyclophosphamide
- Etoposide
- Thioguanine
- Daunorubicin Hydrochloride
Breakdown of trials Ray C. Pais has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ray C. Pais specialize in?
Ray C. Pais focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved BCR-ABL1 fusion positive patients, or patients who are ABL-class fusion positive.
Is Ray C. Pais currently recruiting for clinical trials?
Yes, Ray C. Pais is currently recruiting for 2 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Ray C. Pais has studied deeply?
Yes, Ray C. Pais has studied treatments such as Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Cyclophosphamide.
What is the best way to schedule an appointment with Ray C. Pais?
Apply for one of the trials that Ray C. Pais is conducting.
What is the office address of Ray C. Pais?
The office of Ray C. Pais is located at: East Tennessee Childrens Hospital, Knoxville, Tennessee 37916 United States. This is the address for their practice at the East Tennessee Childrens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.